Sustainable models require asking what a result shows, what design produced it, and whether the design was built to measure value or just produce a number.
|Articles|July 16, 2019
Approaches to Mitigate Blindness Associated with Neovascular Age-Related Macular Degeneration
https://www.pharmacytimes.org/on-demand/a-managed-care-review-approaches-to-mitigate-blindness-associated-with-neovascular-agerelated-macular-degeneration
Advertisement
Advertisement
Related to this article
CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.
Weekend catch-up sleep was associated with lower odds of overactive bladder and milder symptoms, with the benefit concentrated in the first 1.5 hours.
Average stand-alone Part D premiums are projected to rise by less than $1 a month as a temporary subsidy program ends after 2026.
Aligning financial incentives with patient-centered care is becoming an increasingly complex path to navigate within oncology.
Phase 3 trials found oveporexton improved wakefulness, sleepiness, and cataplexy in narcolepsy type 1, with insomnia and urinary frequency common.
The triple agonist also lowered HbA1C by up to 1.6% over 80 weeks, with up to 40% of participants reaching normal levels.
A network meta-analysis found vibegron outperformed mirabegron and tolterodine on several OAB efficacy measures but had higher odds of adverse events.
Advertisement
Advertisement
Trending on AJMC
1
IRA, 340B, Medicaid: The Policy Pressures on Community Oncology
2
Drug Price Drives Value of MASH Therapies More Than Efficacy
3
Retatrutide Yields Up to 20.8% Weight Loss in Obesity With T2D
4
Vibegron Outranks Mirabegron, Tolterodine on Several OAB Measures
5